Myant Enters Exclusive Partnership with Heraeus Medical Components to Produce Textile Solution Incorporating Tecticoat® for Electrical Sensing 

TORONTO, CANADA / HANAU, GERMANY – December 9, 2019 – Myant Inc., industry leaders in textile computing, and Heraeus Medical Components, experts in biomaterials and components for medical devices, manufacturing technologies, and supply chain excellence, have entered into an exclusive partnership to develop, test, prototype and produce a solution leveraging Heraeus’ Tecticoat® coating for electrical sensing applications in textiles. Tecticoat is a conductive polymer-based coating that can be applied to textiles to control electrical conductivity, electromagnetic shielding and electrostatic dissipation, making it an ideal material for integration into connected, on-skin textile applications.

The performance of electrodes that interface with the human body via the skin is governed by the electrical behavior of the materials forming the interface. Traditional electrode designs using electrolytic gels or other adhesives are cumbersome and poorly-suited for broad consumer applications, while dry electrodes tend to vary in performance under different humidity levels and generally suffer due to electrical noise. Heraeus has managed to overcome these challenges using Tecticoat®, a flexible, robust, medically formulated, polymer-based coating that can be applied onto yarns like the ones developed by Myant for its bioelectrical on-skin sensing (e.g. ECG, EEG, EMG) textile applications. The integration of Tecticoat into Myant’s textile-based biosensing and stimulation solutions is positioned to strengthen the company’s leadership in the textile computing industry.

“The quality of data collected from the human body is highly dependent on the quality of the interface between the electrode and the skin,” said Tony Chahine, founder and CEO of Myant. “This partnership with Heraeus to develop a solution using Tecticoat takes us another step closer to building a better bidirectional connection to the human body via textiles.”

“We are excited to enter into this partnership with Myant to develop solutions using Tecticoat,” said Heiko Specht, Executive Vice President of Stimulation and Sensing Solutions and Global Innovation at Heraeus. “This partnership reflects our reputation and history as a leader in materials for advanced technological applications and we look forward to leveraging Myant’s experience in technology integration and yarn-based textile production to further explore Tecticoat’s use in wearables.”

For commercial inquiries or more information, please contact:

Brian Fung
Director of Marketing at Myant
[email protected], 416-423-7906 x401

Frank Florio
VP, Strategy & Business Development at Myant
[email protected], 416-423-7906 x421

About Myant Inc. 

Myant has created the world’s first platform that continuously and ambiently connects people to their bodies, to each other, and to the world around them. Using connected textiles that can sense and react to the human body and a platform that enables machine learning driven health and performance outcomes, Myant is on a mission to transform human connectedness. With an extensive patent portfolio, key exclusive relationships within the textile computing industry, a multidisciplinary team of researchers, engineers, data scientists, fashion designers and knitting specialists, and over 80,000 ft² of manufacturing capacity, Myant is changing the way people across society connect. Connect with us to find out how we can help you create innovative solutions powered by connected textiles and the Myant Platform.

Visit https://www.myant.ca to learn more.

About Heraeus Medical Components and Tecticoat®

Heraeus Medical Components, headquartered in St. Paul, Minnesota, partners with medical device companies to deliver high value solutions to improve patients’ lives worldwide. With over 20 years of expertise in components, optimization and partnership, Heraeus Medical Components brings deep experience and passion to the back end of medical device manufacturing that allows partners to focus on the front-end commercialization process. Tecticoat® was developed by Heraeus as a medically formulated, high-performance conductive coating that improves signal quality in dry applications, features rapid equilibration time for faster use, and is versatile in application on various materials and substrates.

For more information about Heraeus and Tecticoat, please visit http://www.heraeusmedicalcomponents.com.